Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children

Go back to Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
Asianada, Inc. (NASDAQ: ASND) Delayed: 240.87 +1.97 (0.82%)
Previous Close $238.90    52 Week High $21.79 
Open $239.38    52 Week Low $11.92 
Day High $242.18    P/E N/A 
Day Low $236.87    EPS $-0.07 
Volume 139,106